Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 3

Effects of contrast agents on liver

Kontrast maddelerin karaciğere etkileri

Pages
186–189
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Levels of AST, ALT, billirubins and ALP obtained one hour later were similarly in normal ranges whereas alcohol dehidrogenase (an enzyme of liver localized centrilobularily) levels were increased significantly following coronary angiography. (1.1 ± 0.8 U/L vs 2.7 ± 1.2 U/L, p<0.001) Conclusion: Although contrast agents do not affect the parameters representing the diffuse hepatic injury such as AST, ALT, billirubins and ALP, they may lead the alcohol dehidrogenase, representing centrilobuler hepatic injury, to increase.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Aim: Contrast agents have been widely used in interventional cardiology.
📊
Key Findings & Data:The group was composed of 38 male and 18 female.
💡
Conclusion & Impact:Levels of AST, ALT, billirubins and ALP obtained one hour later were similarly in normal ranges whereas alcohol dehidrogenase (an enzyme of liver localized centrilobularily) levels were increased significantly following coronary angiography. (1.1 ± 0.8 U/L vs 2.7 ± 1.2 U/L, p<0.001) Conclusion: Although contrast agents do not affect the parameters representing the diffuse hepatic injury such as AST, ALT, billirubins and ALP, they may lead the alcohol dehidrogenase, representing centrilobuler hepatic injury, to increase.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Karaciğer · Alanin transaminaz · Alkol dehidrogenaz

Abstract

Aim: Aim: Contrast agents have been widely used in interventional cardiology. Although it is clearly known to be having nephrotoxic effects there is not enough data about effects of contrast agents on liver. Material and Methods: Fifty six patients, performed coronary angiography, were included to the study. The group was composed of 38 male and 18 female. Laboratory parameters of hepatic and renal functions of all patients were in normal ranges. Venous blood samples for aspartate aminotransferase (AST), Alanine aminotransferase (ALT), billirubins, Alkelene phosphatase (ALP) and alcohol dehidrogenase levels were obtained before and one hour after the coronary angiography. Student-t test was used for statistically comparison of data. Results: Parameters of hepatic functions obtained before coronary angiography were all in normal ranges. Levels of AST, ALT, billirubins and ALP obtained one hour later were similarly in normal ranges whereas alcohol dehidrogenase (an enzyme of liver localized centrilobularily) levels were increased significantly following coronary angiography. (1.1 ± 0.8 U/L vs 2.7 ± 1.2 U/L, p<0.001) Conclusion: Although contrast agents do not affect the parameters representing the diffuse hepatic injury such as AST, ALT, billirubins and ALP, they may lead the alcohol dehidrogenase, representing centrilobuler hepatic injury, to increase.

Özet

Amaç: Amaç: Kontrast maddeler girişimsel kardiyolojide yaygın olarak kullanılmaktadır. Kontrast maddelerin nefrotoksik etkilere sahip olduğu kesin olarak bilinmekle birlikte karaciğer üzerine olan etkileri konusunda yeterli veri yoktur. Gereç ve yöntem: Çalışmaya koroner anjiografi yapılan 38’i erkek, 18’i kadın 56 hasta alındı. İşlem öncesinde hastalarda çalışılan karaciğer ve böbrek fonksiyon testleri normal sınırlarda idi. Koroner anjiografinin hemen öncesinde ve bir saat sonrasında Aspartat amino transferaz (AST), Alanin amino transferaz (ALT), Alkalen fosfataz (ALP), direkt bilirubin ve total bilirubin ve alkol dehidrogenaz (karaciğerin sentrilobüler bölgesinde lokalize bir enzim) seviyeleri için venöz kan örneği alındı. İşlem öncesi ve sonrası seviyeleri student-t testi ile istatistiksel olarak karşılaştırıldı. Bulgular: Koroner anjiografi öncesi tüm hastalarda AST, ALT, ALP , direkt ve total bilirubin ve alkol dehidrogenaz seviyeleri normaldi. Koroner anjiografiden 1 saat sonra AST, ALT, ALP, direk ve total bilirubin seviyeleri değişmezken, alkol dehidrojenaz enzimi anlamlı bir şekilde yüksek tespit edildi (1.1 ± 0.8 U/L’ye karşılık 2.7 ± 1.2 U/L, p<0.001) Sonuç: Kontrast maddeler yaygın hepatik hasarı gösteren AST, ALT, ALP ve biluribin seviyesine etkileri yokken, sentrlobüler hasarı gösteren alkol dehidrojenaz seviyelerinde artışa neden olmaktadırlar.

🔖

Cite This Article

ÖZMEN, N., APARCI, M., ÖZCAN, Ö., SOLMAZGÜL, E., CİNGÖZBAY, Y., CEBECİ, B. S., DİNÇTÜRK, M. (2006). Effects of contrast agents on liver. MN Kardiyoloji, Cilt: 13 - Sayı: 3, 186–189. https://ajindex.com/articles/297548

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Matthai WH, Kussmaul WG, Krol J, et al. A comparision of low-with high-osmalality contrast agents in cardiac angiography identification of criteria for selective use. Circulation 1994;84:291-301.
  2. Barrett BJ, Parfrey PS, Vasasour HM, et al. A comparision of non-ionic, low-osmolality radiocontrast agents with ionic, highosmolality agents during cardiac catheterization. N Engl J Med 1992;326:431-6.
  3. Piessens JH, Stammen F, Vrolix MC, et al. Effects of an ionic versus a non-ionic low osmolar contrast contrast agent on thrombotic complications of coronary angioplasty. Cathet Cardiovasc Diagn 1993; 28:99-105.
  4. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 2006; 47:439-44.
  5. Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004; 79:211-9. Gavalakis J, du Souich P, Sharkawi M. Acute moderate hypoxia reduces ethanol elimination in the conscious rabbit.Toxicology. 1999; 20;137:109-16.
  6. Sutton AG, Ashton VJ, Campell PG, et al. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs iodixanol 320(Visipaque) in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2002; 57:346-52.
  7. Bertrand ME, Esplugas E, Piessens J, et al. Influence of a non-ionic, iso-osmolar contrast medium (iodixanol) versus an ionic low-osmolar contrast medium (ioxaglate) 0 major cardiac events in patients undergoing percutaneous transluminal coronary angioplasty. Circulation 2000; 101:131-6. Agarwal DP. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol Biol 2001; 49: 703-9
  8. Crabb DW, Dipple KM, Thomasson HR. Alcohol sensitivity,alcohol metabolism, risk of alcoholism and role of alcohol and aldehyde dehydrogenase genotypes, J Lab Clin Med 1993; 122:234-40.
  9. Dohmen K, Baraona E, Ishibashi H, et al. Ethnic differences in gastric sigma-alcohol dehydrogenase activity and ethanol first-pass metabolism. Alcohol Clin Exp Res 1996; 20:1569-76.
  10. Dean PB, Violante MR, Mahoney JA. Hepatic CT contrast enhancement: effect of dose, duration of infusion and time elapsed following infusion. Invest Radiol 1980; 15:158-61.
  11. Dodd GD, Baron RL. Investigation of contrast enhancement in CT of the liver: the need for improved methods. AJR 1993;160:643-6.
  12. Erdoğan C, Savcı G. Helikal BT'de bolus izleme yöntemi kullanılarak farklı eşik değer ve farklı enjeksiyon hızlarının karaciğer boyanması üzerine etkileri. Türk Tanısal ve Girişimsel